Last reviewed · How we verify
Aquamin F
At a glance
| Generic name | Aquamin F |
|---|---|
| Sponsor | Marigot Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Seaweed-Derived Mineral-Rich Nutraceuticals in Cognition (NA)
- Combination Plant-Based Protein and Marine-Based Multi-Mineral Supplement and Bone Remodeling in Young Adults (NA)
- Effects of Aquamin F on NSAID Dose Reduction in Osteoarthritis of the Knee (PHASE1, PHASE2)
- Effects of Aquamin F on Osteoarthritis of the Knee (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aquamin F CI brief — competitive landscape report
- Aquamin F updates RSS · CI watch RSS
- Marigot Ltd. portfolio CI